Global Migraine Drugs Market ,2016–2024
The increasing awareness regarding a migraine and various options available for its treatment are the major factors boosting the growth of the global migraine drugs market
The increasing awareness regarding a migraine and various options available for its treatment are the major factors boosting the growth of the global migraine drugs market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Published By: Zion <strong>Market</strong> Research<br />
<strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>: <strong>Global</strong> Industry Analysis, Size, Share, Growth,<br />
Trends, and Forecasts <strong>2016–2024</strong><br />
Contact Us:<br />
4283, Express Lane, Suite 634-143,<br />
Sarasota, Florida 34249, United States<br />
Tel: +1-386-310-3803 GMT<br />
Tel: +49-322 210 92714<br />
USA/Canada Toll Free No.1-855-465-4651<br />
sales@zionmarketresearch.com
<strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong><br />
<strong>Global</strong> <strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>: Overview<br />
About 12–14% of people around the world suffer from a <strong>Migraine</strong>; it is a type of a headache.<br />
According to regional and international rules, migraine is classified by the nature of the<br />
attack and its frequency into a chronic migraine and episodic migraine. Prophylactic and<br />
abortive are 2 treatments available for the relief of this headache type. Prophylactic<br />
treatment is offered to patients suffering from a chronic migraine in order to avoid migraine<br />
attacks utilizing medications like topiramate, botulinum toxin, and others. Abortive treatment<br />
is offered to terminate severe migraine attack and includes medication like ergot alkaloids,<br />
triptans, and others.<br />
Request Free Sample Report @ https://www.zionmarketresearch.com/sample/migrainedrugs-market<br />
<strong>Global</strong> <strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>: Growth Factors<br />
The increasing awareness regarding a migraine and various options available for its<br />
treatment are the major factors boosting the growth of the global migraine drugs market. A<br />
number of organizations including the American Headache and <strong>Migraine</strong> Association are<br />
taking efforts to spread awareness about a migraine and hence coming up with programs<br />
and providing support to patients so as to spread awareness regarding the disease and
<strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong><br />
further disorders related to a headache. Due to the increasing number of migraine<br />
incidences and rising number of unmet needs in the global migraine drugs market, a<br />
number of companies are planning to invest in the migraine drugs R&D. This, in turn, is<br />
anticipated to propel the global migraine drugs market growth in the near future.<br />
<strong>Global</strong> <strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>: Segmentation<br />
The global migraine drugs market is segmented on the basis of treatment type, route of<br />
administration, and distribution channel. On the basis of treatment type, the global migraine<br />
drugs market is segmented as prophylactic and abortive. The prophylactic treatment<br />
segment is further sub-segmented as topiramate, botulinum toxin, and others. The abortive<br />
treatment segment is further sub-segmented as ergot alkaloids, triptans, and others. On the<br />
basis of route of administration, the global market is classified as injectable, oral, and<br />
others. The others segment is further sub-segmented as transdermal patches and nasal<br />
sprays. On the basis of distribution channel, the global migraine drugs market is diversified<br />
as hospital pharmacies, retail pharmacies, and others.<br />
Request Report TOC (Table of Contents) @<br />
https://www.zionmarketresearch.com/toc/migraine-drugs-market<br />
<strong>Global</strong> <strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>: Regional Analysis<br />
Asia Pacific is anticipated to dominate the global migraine drugs market and is further<br />
expected to continue this trend in the near future. This high growth is mainly owing to the
<strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong><br />
increasing number of people having from a migraine and rising public awareness of the<br />
disease in this region. In addition, China and India are the major developing countries<br />
contributing to the global migraine drugs market growth in the Asia Pacific region; this is<br />
mainly due to the high occurrence of a migraine in these countries. Rising focus on niche<br />
products and their launches along with high penetration of novel drug manufacturers will<br />
further have a positive impact on the growth of the global migraine drugs market in the near<br />
future.<br />
Browse detail report @ https://www.zionmarketresearch.com/report/migraine-drugsmarket<br />
<strong>Global</strong> <strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong>: Competitive Players<br />
Some of the major players in the global migraine drugs market include Endo, Allergan,<br />
Impax Laboratories, Glaxo Smith Kline, Astellas, Amgen, Bayer, AstraZeneca, Dr. Reddy's<br />
Laboratories, Zogenix, CoLucid, Eli Lilly, Eisai, IntelGenx, Ethypharm, and Klara. Other key<br />
players dominating the global market are Johnson & Johnson, Luitpold Pharmaceuticals,<br />
Kowa Pharmaceuticals America, Merck, Meda, Pfizer, OptiNose, Raptor, Pozen, SUDA,<br />
Redhill, TG Therapeutics, Teva, Winston Pharmaceuticals, and Valeant.<br />
For Media Inquiry contact our sales Team @ sales@zionmarketresearch.com
<strong>Migraine</strong> <strong>Drugs</strong> <strong>Market</strong><br />
Zion <strong>Market</strong> Research<br />
Address: 4283, Express Lane, Suite 634-143, Sarasota, Florida 34249, United States<br />
Tel: +1-386-310-3803 GMT<br />
+49-322 210 92714 Tel: +1-855-465-4651 (US/CAN TOLL FREE)<br />
Email: sales@zionmarketresearch.comWeb:www.zionmarketresearch.com